Chromadex Corp
F:OCD1

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
F:OCD1
Watchlist
Price: 2.52 EUR 5.88% Market Closed
Market Cap: €190.4m

Wall St Price Targets

OCD1 Price Targets Summary
Chromadex Corp

There are no price targets for OCD1.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Chromadex Corp Competitors:
Price Targets

Revenue
Forecast

21% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
21% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 19%.

Gross Profit
Forecast

25% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
25% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Chromadex Corp

Operating Income
Forecast

N/A
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Operating Income over the next 3 years is 42%.

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Chromadex Corp

Net Income
Forecast

N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-21%
Average Miss

The compound annual growth rate for Net Income over the next 3 years is 39%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OCD1's stock price target?
Not Available

OCD1 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Chromadex Corp?
Projected CAGR
19%

Over the last 8 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 19%.

What is the Operating Income forecast for Chromadex Corp?
Projected CAGR
42%

The compound annual growth rate for Operating Income over the next 3 years is 42%.

What is the Net Income forecast for Chromadex Corp?
Projected CAGR
39%

The compound annual growth rate for Net Income over the next 3 years is 39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett